The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Calcipotriol/Betamethasone Rowex 50 microgram/g + 0.5 mg/g Ointment

Rowex LtdPA0711/254/001

Main Information

Trade NameCalcipotriol/Betamethasone Rowex 50 microgram/g + 0.5 mg/g Ointment
Active SubstancesCalcipotriol
Dosage FormOintment
Licence HolderRowex Ltd
Licence NumberPA0711/254/001

Group Information

ATC CodeD05AX Other antipsoriatics for topical use
D05AX52 calcipotriol, combinations


License statusAuthorised
Licence Issued29/01/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back